FPOLayout for review — draft content, for placement only. Imagery and claims shown from global material pending Canadian adaptation. Ghosted items show the future full website.
PrFREHEMGO®denecimig injectionMy profileFPOENFR

FREHEMGO®: The only* once-monthly HA PPx to normalise thrombin generation all month long1,2

A direct switch from emicizumab to FREHEMGO® increased thrombin peak height by 79%, to normal levels, without excessive response — both during and after elimination of emicizumab.†2,3 FPO

TG (nmol/L) over 26 weeks — emicizumab → FREHEMGO® switchFPO
Switching from emicizumab to FREHEMGO® increased thrombin generation to normal levels†2,3FPO

Adapted from Hermans, et al., 2026.2

Full website

How FREHEMGO® works — mechanism of action video

MOA content lands on the full website (per Aalia, 2026-08-12) — shown here so the growth path is visible.

View more

Study imageryFPO

The freedom of zero bleeds

Discover powerful protection at every stage of the hemophilia journey.

Explore efficacy data
Patient imageryFPO

A proven safety profile

Ultra-potent protection without compromising on safety profile.

Explore safety data
Pen line-upFPO

Dosing made simple

No mg/kg dosing. No dose calculations — 5 prefilled pens.

Discover dosing